Overcoming inefficiencies to improve access to cell and gene therapy
Drug Discovery World
MARCH 13, 2023
Between the 24 therapies already approved by the FDA 1 and a marked increase in clinical trials, widespread accessibility to precision medicine feels within reach. ELISA, ELISpot), and cytotoxicity assays, single cell and whole genome sequencing, SNP analysis, and rapid sterility methods to characterise cell therapies.
52 
Let's personalize your content